SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

NanoViricides (NYSE-A:NNVC) said on Tuesday it has filed an application with the US Food and Drug Administration for Rare ...

A new study in the journal Pediatrics has found that medication non-adherence increases healthcare use in pediatric patients with chronic medical conditions. Researchers meta-analyzed 10 studies that ...

Plus Therapeutics Inc. (NASDAQ:PSTV) said the U.S. Food and Drug Administration has granted Orphan Drug Designation to ...

The médiEval French tool was adapted into the MAEva tool for the African context through a three-stage process: content review by a multidisciplinary group, content ...

Please provide your email address to receive an email when new articles are posted on . Nearly half of all teens with a history of cardiac surgery still used more than one medication. Clinicians must ...

FDA grants orphan drug designation to rhenium (186Re) obisbemeda for pediatric glioma and ependymoma, supported by the phase ...

Ann Arbor-based University of Michigan has developed a statewide initiative aimed at reducing pediatric medication errors, making it the first state to standardize drug concentration levels in ...

Biopsy-derived organoids, accurate models of disease, are used to search for new drugs. Now, results obtained by a study led by the University of Trento in collaboration with Bambino Gesù Children's ...

For pediatric patients with drug-resistant focal epilepsy, stereoelectroencephalography-guided radiofrequency ...

The European Medicines Agency has backed expanding Namuscla to address muscle rigidity in children and adolescents with rare inherited neuromuscular conditions.